Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 4.10.2023Zentiva, k.s. (ZNT-1)2517DZetovar 10 mg/80 mg tablety (tbl 90x10 mg/80 mg (blis.OPA/Al/PVC))4.10.2023R
 4.10.2023Zentiva, k.s. (ZNT-1)33494NEUROL 0,5 (tbl 30x0,5 mg (blis. PVC/PVDC/Al))4.10.2023R
 4.10.2023Fresenius Kabi AB (FRK-S)06388KABIVEN PERIPHERAL (emu inf 1x1920 ml (vak Excel))4.10.2023Z
 4.10.2023Fresenius Kabi AB (FRK-S)06365KABIVEN PERIPHERAL (emu inf 1x1440 ml (vak Excel))4.10.2023Z
 4.10.2023Upjohn EESV (UPO-NL)62568Norvasc 10 mg tablety (tbl 30x10 mg (blis.PVC/PVDC/Al))10.10.2023R
 4.10.2023Upjohn EESV (UPO-NL)62569Norvasc 5 mg tablety (tbl 30x5 mg (blis.PVC/PVDC/Al))5.10.2023R
 4.10.2023G.L. Pharma GmbH (GLH-2)52014Topilex 50 mg (tbl flm 60x 50 mg (blis.PVC/PE/PVDC/Al))4.10.2023Z
 4.10.2023G.L. Pharma GmbH (GLH-2)7406BGerasa 100 mg gastrorezistentné tablety (tbl ent 30x100 mg (blis.PVC/Al))4.10.2023Z
 4.10.2023ratiopharm GmbH (RAT)36737Valpro-ratiopharm Chrono 500 mg (tbl plg 100x500 mg (blis.Al/PVC))16.10.2023O
 4.10.2023Bristol-Myers Squibb Pharma EEIG (BMS-IE)64369Vidaza 25 mg/ml prášok na injekčnú suspenziu (plv inu 1x100 mg (liek.inj.skl.))20.12.2023Z
 3.10.2023TS Pharma s.r.o. (TPH-1)02680MeniSerc 16 (tbl 60x16 mg (blis.PVC/PVDC/Al))4.10.2023O
 3.10.2023Sandoz Pharmaceuticals d.d. (SAN-SLO-1)3000DDailiport 3 mg (cps pld 30x1x3 mg (blis.PVC/PVDC/Al-jednotliv.dáv.))2.10.2023R
 3.10.2023Sandoz Pharmaceuticals d.d. (SAN-SLO-1)3008DDailiport 5 mg (cps pld 30x1x5 mg (blis.PVC/PVDC/Al-jednotliv.dáv.))2.10.2023R
 3.10.2023Teva B.V. (TEV-NL-4)0478EAtorvastatín/Ezetimib Teva 40 mg/10 mg (tbl flm 30x40 mg/10 mg (blis.OPA/Al/PVC/Al))15.12.2023R
 3.10.2023Teva B.V. (TEV-NL-4)09292Ramipril Actavis 10 mg (tbl 98x10 mg (blis.Al/Al))10.12.2023R

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To